Summary & Overview
CPT 53866: Removal of Temporary Prostatic Urethral Compression Device
CPT code 53866 denotes the endoscopic removal of a temporary device from the prostatic urethra that compresses prostate tissue to induce ischemia and improve urine flow. This procedure is relevant nationally as a minimally invasive option for relieving lower urinary tract obstruction related to prostatic tissue, offering an alternative to more invasive surgical approaches. It has implications for surgical pathway planning, outpatient procedural capacity, and device-related care coordination.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for CPT code 53866, how the service is typically delivered and where it is performed, and what to expect in terms of coding and billing themes. The publication summarizes common modifiers and payer considerations when available, highlights benchmarks where provided, and outlines policy and coding updates that affect national coverage and reimbursement patterns.
This national-level summary is intended for health system billing managers, coding professionals, and clinicians involved in procedural urology. It provides the essential clinical and administrative context needed to align coding practice with operational and payer requirements.
Billing Code Overview
CPT code 53866 describes a procedure in which a provider uses a catheter to remove a temporary implant from the portion of the urethra that passes through the prostate. The implanted device compresses prostate tissue to induce ischemia, reducing tissue bulk to relieve urethral obstruction and improve urinary flow.
-
Service type: Endoscopic removal of a temporary prostatic urethral compression device
-
Typical site of service: Outpatient procedural setting or ambulatory surgery center; may also occur in an operating room when clinically indicated
Clinical & Coding Specifications
Clinical Context
A 68-year-old male with symptomatic benign prostatic hyperplasia (BPH) presents with progressive urinary hesitancy, weak stream, nocturia, and incomplete emptying despite medical therapy. After evaluation including uroflowmetry, post-void residual measurement, and cystoscopy confirming obstruction at the prostatic urethra, the urology team plans removal of a temporary prostatic urethral device that was previously placed to compress prostatic tissue and induce ischemia to improve urinary flow. The patient arrives to an outpatient ambulatory surgery center for the procedure. The workflow includes preoperative verification, review of prior device placement and imaging, informed consent specific to device removal, anesthesia assessment (often monitored anesthesia care or local with sedation), placement of a urethral catheter or cystoscopic sheath as needed, endoscopic visualization, and use of a retrieval catheter or forceps to remove the temporary ischemia-inducing prostatic device from the prostatic urethra. Hemostasis is confirmed, the urethra inspected for trauma, and a Foley catheter may be left temporarily for urinary drainage. Postoperative monitoring is brief; discharge instructions address voiding expectations, infection signs, and follow-up with urology for assessment of symptom improvement and potential need for additional therapy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier / standard reporting | Use when no special circumstance applies for this service. |